{"id":197059,"name":"BROWN RUDNICK, LLP, ON BEHALF OF PRIME THERAPEUTICS","slug":"brown-rudnick-llp-on-behalf-of-prime-therapeutics","state":"DC","country":"United States of America","description":"Law Firm","totalSpending":40000,"filings":6,"yearlySpending":[{"year":2018,"income":40000},{"year":2019,"income":0}],"issues":["HCR","MMM","PHA"],"firms":["HOOPER, LUNDY & BOOKMAN, P.C."],"lobbyists":["MARTIN CORRY","LISA LAYMAN"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Issues relating to the regulation of PBMs and healthcare.","Issues relating to the regulation of PBMs and healthcare.","Issues relating to the regulation of PBMs and healthcare.","H.R.2212 and S.974 - Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (or the CREATES Act of 2017); H.R. 1316 - The Prescription Drug Price Transparency Act; S.771 and H.R.1776 - ","H.R.6-SUPPORT for Patients and Communities Act; H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act; H.R. 3528 & S. 2460-Every Prescription Conveyed Securely"],"years":[2018,2019]}